CYP2D6 and CYP2C19 in papua new guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess

International Journal of Molecular Epidemiology and Genetics

Volumn 1, Issue 4, 2010, Pages 310-319

  von Ahsen, Nicolas ^a   Tzvetkov, Mladen ^a   Karunajeewa, Harin A ^b   Gomorrai, Servina ^c   Ura, Alice ^c   Brockmöller, Jürgen ^a   Davis, Timothy M E ^b   Mueller, Ivo ^c   Ilett, Kenneth F ^b   Oellerich, Michael ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

CYP2C19; CYP2D6 gene polymorphism; Heterozygote excess; Novel alleles; Papua new guinea

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2D6;

ALLELE; ARTICLE; BLOOD SAMPLING; CHROMATIN IMMUNOPRECIPITATION; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; PAPUA NEW GUINEA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78449253953     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005; 5: 6-13.
2. Eichelbaum M, Ingelman-Sundberg M, Evans WE. Pharmacogenomics and individualized drug therapy. Annu Rev Med 2006; 57: 119-137.
3. Weinshilboum R. Inheritance and drug response. N Engl J Med 2003; 348: 529-537.
4. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics 2007; 17: 93-101.
5. Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics 2009; 19: 170-179.
6. Masta A, Lum JK, Tsukahara T, Hwaihwanje I, Kaneko A, Paniu MM, Sapuri M, Takahashi N, Ishizaki T, Kobayakawa T, Hombhanje FW. Analysis of Sepik populations of Papua New Guinea suggests an increase of CYP2C19 null allele frequencies during the colonization of Melanesia. Pharmacogenetics 2003; 13: 697-700.
7. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 2002; 41: 913-958.
8. Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM. A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med 2008; 359: 2545-2557.
9. Genton B, al-Yaman F, Beck HP, Hii J, Mellor S, Narara A, Gibson N, Smith T, Alpers MP. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol 1995; 89: 359-376.
10. de Leon J, Susce MT, Murray-Carmichael E. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. Mol Diagn Ther 2006; 10: 135-151.
11. Heller T, Kirchheiner J, Armstrong VW, Luthe H, Tzvetkov M, Brockmöller J, Oellerich M. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit 2006; 28: 673-677.
12. Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, Leeder JS. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 2008; 83: 234-242.
13. Sachse C, Brockmöller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997; 60: 284-295.
14. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005; 21: 2128-2129.
15. Weir BS, Cockerham CC. Estimating F-statistics for the analysis of population structure. Evolution 1984; 38: 1358-1370.
16. Rousset F. GENEPOP'007: a complete reimplementation of the GENEPOP. Mol Ecol Res 2008; 8: 103-106.
17. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
18. Doyle JM. What race and ethnicity measure in pharmacologic research. J Clin Pharmacol 2006; 46: 401-404.
19. Harty L, Johnson K, Power, A. Race and ethnicity in the era of emerging pharmacogenomics. J Clin Pharmacol 2006; 46: 405-407.
20. Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat Genet 2004; 36: S28-S33.
21. Witherspoon DJ, Wooding S, Rogers AR, Marchani EE, Watkins WS, Batzer MA, Jorde LB. Genetic similarities within and between human populations. Genetics 2007; 176: 351-359.
22. Neel JV, Ward RH. The genetic structure of a tribal population, the Yanomama Indians. VI. Analysis by F-statistics (including a comparison with the Makiritare and Xavante). Genetics 1972; 72: 639-666.
23. McLellan RA, Oscarson M, Seidegard J, Evans DA, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics 1997; 7: 187-191.
24. Aklillu E, Herrlin K, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden. Pharmacogenetics 2002; 12: 375-383.
25. Friedlaender JS, Friedlaender FR, Reed FA, Kidd KK, Kidd JR, Chambers GK, Lea RA, Loo JH, Koki G, Hodgson JA, Merriwether DA, Weber JL. The genetic structure of Pacific Islanders. PLoS Genet 2008; 4: e19-.
26. Long JC, Naidu JM, Mohrenweiser HW, Gershowitz H, Johnson PL, Wood JW, Smouse PE. Genetic characterization of Gainjand Kalam-speaking peoples of Papua New Guinea. Am J Phys Anthropol 1986; 70: 75-96.
27. Harpending H. Genetic structure of small populations. Ann Rev Anthropol 1974; 3: 229-243.
28. Karlin S. Levels of multiallelic overdominance fitness, heterozygote excess and heterozygote deficiency. Theor Popul Biol 1990; 37: 129-149.
29. Kaneko A, Bergqvist Y, Taleo G, Kobayakawa T, Ishizaki T, Bjorkman A. Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations. Pharmacogenetics 1999; 9: 317-326.
30. Alvarez G. Deviations from Hardy-Weinberg proportions for multiple alleles under viability selection. Genet Res 2008; 90: 209-216.
31. Wiesenfeld SL, Gajdusek DC. Genetic structure and heterozygosity in the Kuru region, eastern highlands of New Guinea. Am J Phys Anthropol 1976; 45: 177-189.
32. Thompson EA, Roberts DF. Kinship structure and heterozygosity on Tristan da Cunha. Am J Hum Genet 1980; 32: 445-452.
33. Cornuet JM, Luikart G. Description and power analysis of two tests for detecting recent population bottlenecks from allele frequency data. Genetics 1996; 144: 2001-2014.
34. Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 1989; 45: 889-904.